InSpire MD Reports Financial Results For Quarter Ended September 30, 2013

BOSTON, Nov. 11, 2013 /PRNewswire/ -- InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced financial results for the quarter ended September 30, 2013.

Key Highlights of Recent Events

•MGuard™ outperformed bare metal and drug eluting stents in all-cause mortality in STEMI patients for the 12-month follow-up data from the MASTER Trial

Help employers find you! Check out all the jobs and post your resume.